Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extracellular Vesicles for Diabetic Foot Ulcers
NCT06825884Phase 1Active, not recruiting
- Sponsor
- University of Jordan
- Start
- Dec 2024
- Primary completion
- Dec 2027
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Extracellular vesicles (University of Jordan) in diabetic foot ulcer (DFU), sponsored by University of Jordan. Primary endpoint: Short-term speed and effectiveness of extracellular micro vesicles (EV) on the healing of diabetic foot ulceration at 12 months. Started Dec 2024; status: active, not recruiting.
02
Drugs
Extracellular vesicles (University of Jordan)
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT06825884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06825884.